Phase I Study of [14C]Zorifertinib Shows Promising Safety and Pharmacokinetics
[14C]Zorifertinib is undergoing Phase I study to evaluate its safety and pharmacokinetics in healthy males.
Company
Pharmaceutical intelligence for Alpha Biopharma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.